TIDMODX

RNS Number : 2347N

Omega Diagnostics Group PLC

08 May 2018

Omega Diagnostics Group PLC

("Omega" or the "Company")

Allersys(R) CE-Mark

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked two additional allergens, extending the menu to 53 allergens which can be run on the fully automated IDS Instrument.

These allergens will be supplied to IDS under the global distribution agreement announced on 20 April 2018. Ongoing investment to increase the menu is supported by the research and development grant of up to GBP1.8 million, which the Company secured from Scottish Enterprise in August 2016.

Contacts:

 
 Omega Diagnostics Group             Tel: 01259 763 030 
  PLC 
 Colin King, Chief Executive   www.omegadiagnostics.com 
 Kieron Harbinson, Group 
  Finance Director 
 
 finnCap Ltd                         Tel: 020 7220 0500 
 Geoff Nash/James Thompson 
  (Corporate Finance) 
 Camille Gochez/ Abigail 
  Wayne (Corporate Broking) 
 
 Walbrook PR Limited              Tel: 020 7933 8780 or 
                                   omega@walbrookpr.com 
 Paul McManus                        Mob: 07980 541 893 
 Lianne Cawthorne                    Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFMGGKKDNGRZM

(END) Dow Jones Newswires

May 08, 2018 02:00 ET (06:00 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omega Diagnostics Charts.